Dr. George Busby, CSO & Co-founder of Allelica (300 × 214 px) (1920 × 800 px) (1920 × 1080 px)

9 September 2021 

Discover the role of Polygenic Risk Score (PRS) in advanced genomic risk assessment and precision healthcare in the UK.

In this webinar, experts explore the current clinical application of PRS, future opportunities, and the obstacles to widespread adoption. Dr. Nick Lench, CSO at Congenica, and Dr. George Busby, CSO at Allelica, discuss innovative applications for scalable genomic risk analysis of common diseases.

During this webinar, you will learn about:

  • The latest developments in Polygenic Risk Score research and clinical application
  • Advances in genomic risk assessments for common diseases like breast cancer
  • Emerging technologies available for PRS application at scale.